# Tirzepatide – 60mg/vial · 10-Vial Pack (Research Use Only)

**Independent lab result · batch PTW-Tirz-2608-001**

Tirzepatide 60mg. Tested by Janoshik Analytical (task #239838), analysis conducted 7 Oct 2026. The sample was pulled from our own stock, submitted and paid for by Portal to Wellness, and the report names us as the client.

- Identity: tirzepatide, confirmed by blind test
- Measured content: 65.05 mg per vial (labelled 60 mg)
- Purity: 99.740% (HPLC)

[View and verify the full report on Janoshik’s site →](https://verify.janoshik.com/tests/239838-Tirzepatide_60mg_IBKT34GIRCJT)

This result applies to batch PTW-Tirz-2608-001, the batch currently shipping. The batch number is printed on the vial label. See all published results on our [Lab Testing & Verification](https://portaltowellness.net/lab-verification-quality-testing/) page.

Overview
A ten-vial pack of research-grade Tirzepatide, 60mg per vial, supplied as a lyophilized powder. Tirzepatide is a synthetic dual GIP and GLP-1 receptor agonist peptide studied in the published literature for its interaction with incretin receptor signalling.

Supplied for laboratory and identification research purposes only. Not for human or veterinary use.

---

Source: https://portaltowellness.net/shop/tirzepatide-60mg-10-vial-pack/
Research use only. Terms: https://portaltowellness.net/research-use-only/